Vaccines to curb F&P Healthcare sales

Vaccines to curb F&P Healthcare sales
Dan Brunskill
Shares in Fisher & Paykel Healthcare surged last week as investors were swayed by sustained high sales numbers, but Forsyth Barr is warning demand may begin to fade as covid vaccinations roll out globally.The healthcare manufacturer saw its shares jump more than 5 percent on Friday on the news that revenue was up 73 percent in the nine months ended December, pulling the stock back above $35.Chief executive Lewis Gradon said high rates of covid-19 hospitalisations had driven strong demand for its hospital products, which are used as a front-...

More Markets

NZ sharemarket celebrates a near 1% Easter rise
Markets Market close

NZ sharemarket celebrates a near 1% Easter rise

The S&P/NZX 50 Index closed at 12,105.29, up 94.62 points or 0.79%.

Graham Skellern 28 Mar 2024
F&P Healthcare facing $12m bill for product recall
Markets

F&P Healthcare facing $12m bill for product recall

The company will provision the cost in its next full year results.

Staff reporters 28 Mar 2024
Synlait seeking help from major shareholder for $130m debt
Markets

Synlait seeking help from major shareholder for $130m debt

Synlait enters trading halt as it needs more time to come up with cash.